Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | NAAA | Q02083 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5079277 | 0.94 | FAAH (0.54) | FAAHTSHRCNR1CNR2ALDH1A1 | |
| SCHEMBL11195272 | 0.93 | FAAH (0.57) | FAAHTSHRCNR1CNR2ALDH1A1 | |
| SCHEMBL5070394 | 0.93 | FAAH (0.57) | FAAHTSHRCNR1CNR2ALDH1A1 | |
| SCHEMBL28425270 | 0.93 | FAAH (0.57) | FAAHTSHRCNR1CNR2ALDH1A1 | |
| SCHEMBL2312371 | 0.93 | FAAH (0.57) | FAAHTSHRCNR1CNR2ALDH1A1 | |
| SCHEMBL1138701 | 0.93 | FAAH (0.57) | FAAHTSHRCNR1CNR2ALDH1A1 | |
| SCHEMBL19614589 | 0.93 | FAAH (0.57) | FAAHTSHRCNR1CNR2ALDH1A1 | |
| SCHEMBL1138575 | 0.93 | FAAH (0.57) | FAAHTSHRCNR1CNR2ALDH1A1 | |
| SCHEMBL300866 | 0.93 | FAAH (0.57) | FAAHTSHRCNR1CNR2ALDH1A1 | |
| SCHEMBL28988573 | 0.93 | FAAH (0.57) | FAAHTSHRCNR1CNR2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 298 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260011732-A1 | ON-CONDUCTIVE POLYMER, AND LITHIUM SECONDARY BATTERY ELECTRODE AND LITHIUM SECONDARY BATTERY WHICH COMPRISE SAME | SAMSUNG SDI CO. LTD. (KR) | 2026-01-08 | — | — | US | claimed |
| EP-4413055-B1 | STABILIZED RHEOLOGY MODIFIER EMULSIONS | LUBRIZOL ADVANCED MAT INC (US) | 2025-12-03 | — | — | EP | claimed |
| EP-4019560-B1 | ION CONDUCTIVE POLYMER, AND LITHIUM SECONDARY BATTERY ELECTRODE AND LITHIUM SECONDARY BATTERY WHICH COMPRISE SAME | SAMSUNG SDI CO LTD (KR) | 2025-10-29 | — | — | EP | claimed |
| US-20250300179-A1 | ION-CONDUCTIVE POLYMER, AND LITHIUM SECONDARY BATTERY ELECTRODE AND LITHIUM SECONDARY BATTERY WHICH COMPRISE SAME | SAMSUNG SDI CO LTD (KR) | 2025-09-25 | — | — | US | claimed |
| US-20250140857-A1 | ION-CONDUCTIVE POLYMER, AND LITHIUM SECONDARY BATTERY ELECTRODE AND LITHIUM SECONDARY BATTERY WHICH COMPRISE SAME | SAMSUNG SDI CO., LTD. (KR) | 2025-05-01 | — | — | US | claimed |
| WO-2025024325-A2 | ALL-ACRYLIC TRIBLOCK AND TETRABLOCK COPOLYMERS HAVING A LACTAM MOIETY AND APPLICATIONS THEREOF | ISP INVESTMENTS LLC (US) | 2025-01-30 | — | — | WO | claimed |
| US-20250002704-A1 | STABILIZED RHEOLOGY MODIFIER EMULSIONS | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2025-01-02 | — | — | US | claimed |
| CN-119144256-A | Optical cement and preparation method thereof | 江西福塬化工有限责任公司 | 2024-12-17 | — | — | CN | claimed |
| EP-4413055-A1 | STABILIZED RHEOLOGY MODIFIER EMULSIONS | Lubrizol Advanced Materials, Inc. (US) | 2024-08-14 | — | — | EP | claimed |
| CN-118076656-A | Stabilized rheology modifier emulsions | 路博润先进材料公司 | 2024-05-24 | — | — | CN | claimed |
| CN-108495892-A | Method for producing polyformaldehyde injection molding object | SABIC环球技术有限责任公司 | 2018-09-04 | — | — | CN | claimed |
| US-9822277-B2 | Adhesion improver for amine curing epoxy resin paint | KUSUMOTO CHEMICALS, LTD. (JP) | 2017-11-21 | — | — | US | claimed |
| WO-2017162393-A1 | POLYMER COMPOSITION COMPRISING A (METH)ACRYLIC POLYMER HAVING GOOD OPTICAL PROPERTIES AND HEAT RESISTANCE | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2017-09-28 | — | — | WO | claimed |
| WO-2017102233-A1 | PROCESS FOR PRODUCTION OF POLYOXYMETHYLENE INJECTION MOULDED OBJECTS | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2017-06-22 | — | — | WO | claimed |
| EP-2749609-B1 | Adhesion improver for amine curing epoxy resin paint | KUSUMOTO CHEMICALS (JP) | 2016-08-03 | — | — | EP | claimed |
| US-20140187670-A1 | ADHESION IMPROVER FOR AMINE CURING EPOXY RESIN PAINT | KUSUMOTO CHEMICALS, LTD. (JP) | 2014-07-03 | — | — | US | claimed |
| EP-2749609-A1 | Adhesion improver for amine curing epoxy resin paint | Kusumoto Chemicals, Ltd. (JP) | 2014-07-02 | — | — | EP | claimed |
| CN-102140155-B | Ultraviolet light or electron beam-cured resin composition for blue-ray disc | Hunan honghai new material co ltd | 2013-04-10 | — | — | CN | claimed |
| CN-102404989-A | Dispersants for agricultural applications | AKZO NOBEL CHEMICALS INTERNAT | 2012-04-04 | — | — | CN | claimed |
| CN-102140155-A | Ultraviolet light or electron beam-cured resin composition for blue-ray disc | Hunan honghai new material co ltd | 2011-08-03 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250002704-A1 | STABILIZED RHEOLOGY MODIFIER EMULSIONS | SORD, SCD, DEGS1 | FAAH 413/4885TSHR 4436/4885CNR1 805/4885 |
| US-20260011732-A1 | ON-CONDUCTIVE POLYMER, AND LITHIUM SECONDARY BATTERY ELECTRODE AND LITHIUM SECONDARY BATTERY WHICH COMPRISE SAME | SCN10A, SCN11A, KCNK10 | FAAH 2647/4885TSHR 2631/4885CNR1 2172/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.